STRIDE sustained an overall survival benefit with safety profiles in unresectable hepatocellular carcinoma at 5-year follow-up
Fields of Study & Subjects
Hepatocellular Carcinoma Treatment and Prognosis
Cholangiocarcinoma and Gallbladder Cancer Studies
Liver Disease Diagnosis and Treatment
Publication details
- Journal / source
- HepatoBiliary Surgery and Nutrition
- Publisher
- AME Publishing Company
- Volume
- 15
- Issue
- 1
- Pages
- 17–17
- Publication date
- 21 January 2026
- Language
- EN